Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Vivek Abhyankar (NPI 1083607089)

Field	Value
Entity Type	Individual
Organization	Vivek Abhyankar
Address	400 Matthew St
City	Marietta
State	OH
ZIP	45750
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	August 24, 2005

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider is effectively single‑payer with respect to public programs: total Medicare revenue is $1.9M and there is no Medicaid billing on file, so Medicare accounts for essentially all reported public‑payer activity. The absence of Medicaid billing suggests analysts should treat this profile as Medicare‑driven when modeling payer risk or network exposure.

Revenue is highly concentrated in a small set of biologic oncology drugs: the precomputed top‑3 Medicare codes (J9271, J9299, J1569) account for 75.3% of the provider's Medicare revenue. In dollar terms those three codes together include J9271 at $928.8K (49.7% of Medicare revenue), J9299 at $302.4K (16.2%), and J1569 at $176.4K (9.4%), indicating a narrow set of high‑impact revenue drivers.

The CPT/HCPCS mix is consistent with an infusion‑based hematology/oncology practice that emphasizes immunotherapy and supportive biologics: J9271 (pembrolizumab) and J9299 (nivolumab) dominate revenue, supported by immune globulin (J1569) and frequent use of chemotherapy administration codes such as 96413 and 96365. This pattern implies day‑treatment/infusion operations rather than predominantly outpatient clinic evaluation visits.

Despite J9271 (pembrolizumab) representing nearly half of Medicare revenue ($928.8K, 49.7%), the provider's national ranking on volume for that drug is not extreme: J9271 ranks #319 of 1841 providers and is described as 83th percentile; typical, unremarkable volume. In other words, the provider derives outsized revenue concentration from J9271 while still operating at a common national utilization level for that specific code.

Other top codes show mixed competitive standing: J9299 (nivolumab) is $302.4K and ranks #294 of 505 (42th percentile; typical, unremarkable volume), while J1569 (immune globulin) is $176.4K and ranks #188 of 542 (65th percentile; typical, unremarkable volume). These ranks indicate a modest‑to‑moderate presence in national peer comparisons for the provider’s secondary drug lines.

There are clear high‑frequency, low‑unit‑price items in the billing mix that shape revenue differently: J0881 (darbepoetin alfa) records 48.1K claims at $2 avg paid/claim for $96.2K (5.1% of Medicare revenue) and is ranked #70 of 1114 (94th percentile; notably above typical national volume). This suggests large volumes of small‑unit administrations that collectively contribute meaningful revenue and operational throughput.

Several administration/injection codes are notable relative to peers and point to heavy infusion activity: 96372 has 486 claims and is ranked #1715 of 58224 (97th percentile; notably above typical national volume), and multiple chemotherapy administration add‑on codes (96413, 96417, 96415) appear across the top 25 list. These elevated percentiles for administration codes reinforce an operations profile built around repeated in‑clinic infusions and injections.

The provider has long tenure in the NPI registry (enumerated 2005‑08‑24, ~21 years ago), which supports the interpretation that these billing patterns are established and not a short‑term artifact. For payers and competitive analysts, that longevity combined with a concentrated infusion/drug mix suggests stable referral and treatment pathways rather than a new or transient practice model.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

49 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	21,600	$40	$928.8K
J9299	Injection, nivolumab, 1 mg	12,600	$20	$302.4K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	4,900	$40	$176.4K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	48,100	$1	$96.2K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	900	$80	$71.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	640	$90	$57.9K
J0897	Injection, denosumab, 1 mg	2,940	$20	$52.9K
J1437	Injection, ferric derisomaltose, 10 mg	2,600	$20	$44.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	430	$100	$40.9K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	170	$130	$20.8K

Showing 1–10 of 49

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 49 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Vivek Abhyankar — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

49 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	6	40	12,100	$40	$603K
J9299	4	10	13,660	$20	$376.8K
J1569	9	20	4,900	$40	$203.8K
J0897	114	230	2,880	$20	$79.5K
J3490	20	50	100	$560	$73.1K
J2506	3	10	480	$80	$49.8K
J0881	1	20	14,800	$1	$36.6K
J1437	2	20	1,700	$20	$34.9K
J9217	86	100	120	$130	$22.3K
96413	20	210	130	$90	$16.8K

Showing 1–10 of 49

Related Providers

Other providers that share a Tax Identification Number (TIN) with Vivek Abhyankar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Cleveland Clinic Foundation	OH	General Acute Care Hospital	$0	$864.1M
Ohiohealth Corporation	OH	Family Medicine Physician	$0	$89.1M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Partners Physician Group	OH	Surgery Physician	$0	$28.5M
Quick Med Urgent Care LLC	OH	Urgent Care Clinic/Center	$0	$21.8M
Clinic Medical Services Company LLC	OH	Diagnostic Radiology Physician	$0	$10.8M
Cleveland Clinic Home Care Services	OH	Community Based Hospice Care Agency	$0	$10.8M
The Cleveland Clinic Foundation	OH	Clinical Medical Laboratory	$144K	$9M
Wooster Clinic, LLC	OH	Multi-Specialty Clinic/Center	$0	$6.9M
Community Memorial Hospital Association	MN	Critical Access Hospital	$0	$4.3M

Nearby Providers

Other providers in the same ZIP code as Vivek Abhyankar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Marietta Memorial Hospital	OH	General Acute Care Hospital	$0	$102.2M
Quality Of Life Home Care, Ltd	OH	Home Health Agency	$0	$15.9M
Marietta Home Health And Hospice, L.L.C.	OH	Community Based Hospice Care Agency	$0	$7.6M
L & P Services, Inc.	OH	Public Health or Welfare Agency	$0	$7.2M
Marietta Health Care Physicians, Inc	OH	Emergency Medicine Physician	$0	$6.9M
Frederic Humphrey	OH	Internal Medicine Physician	$71.1K	$978.4K
Mahyar Tahbaz	OH	Nephrology Physician	$335K	$540.4K
City Of Marietta	OH	Ambulance	$257.6K	$486.6K
Matthew Macatol	OH	Anatomic Pathology & Clinical Pathology Physician	$348.7K	$470
David Montgomery	OH	Internal Medicine Physician	$218K	$0

Vivek Abhyankar — Billing Profile & Reimbursement Data

Sign up for Vivek Abhyankar — Billing Profile & Reimbursement Data policy alerts

Vivek Abhyankar — Billing Profile & Reimbursement Data

Sign up for Vivek Abhyankar — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References